Akynzeo 300-0.5 MG capsules
Ended Awarded Last action
- Contract number
- SPE2DR26F9LC7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,673
Award facts
- Contract value 100% obligated
- $25,673.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of AKYNZEO 300-0.5 mg capsules (an antiemetic medication used to prevent chemotherapy-induced nausea and vomiting). This firm fixed-price delivery order, valued at $25,673.04 with an ultimate completion date of January 15, 2026, represents a child contract under the company's parent organization, Cencora, Inc. The contract was awarded on a non-set-aside basis through full and open competition, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements. Performance will be fulfilled from AmerisourceBergen Drug Corp's Conshohocken, Pennsylvania facility, which serves as the company's corporate office and primary distribution hub.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The IDC structure allows the Defense Logistics Agency to efficiently procure critical pharmaceutical products across multiple therapeutic domains through this established vehicle rather than conducting individual full and open competitions for each requirement.
Quick answers
Who was awarded contract SPE2DR26F9LC7?
SPE2DR26F9LC7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9LC7 worth?
The government has obligated $25,673 on SPE2DR26F9LC7.
Is contract SPE2DR26F9LC7 an order under another contract?
Yes. SPE2DR26F9LC7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LC7 competed?
The extent of competition for SPE2DR26F9LC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award